Conference
Experiences with continuous infusion of recombinant activated factor VII.
Abstract
A questionnaire was sent to 28 haemophilia treatment centres known to have used recombinant activated factor VII (rFVIIa; NovoSeven, Novo Nordisk, Bagsvaerd, Denmark), to collect data on continuous infusion of this product. This mode of administration was recently introduced for rFVIIa but there are several questions which remain to be answered in order to optimize this technique. Of the 26 responding centres, 14 had used rFVIIa in continuous …
Authors
Schulman S; d'Oiron R; Martinowitz U; Pasi J; Briquel ME; Mauser-Bunschoten E; Morfini M; Ritchie B; Goudemand J; Lloyd J
Volume
9 Suppl 1
Pagination
pp. s97-101
Publication Date
March 1998
Conference proceedings
Blood Coagulation & Fibrinolysis
ISSN
0957-5235